Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
lunes, octubre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Rapid Micro Biosystems Inc
RPID
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.7644
-0.0807
-9.55%
Últ. Act.: Oct 19, 4:42 AM
$0.7644
-0.0807
-9.55%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Privacy Manager
Rapid Micro Biosystems Financials
Rapid Micro Biosystems (RPID) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.133M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.133 million estimate.
Benzinga Newsdesk
PRO
Rapid Micro Biosystems Q2 EPS $(0.27) Misses $(0.24) Estimate, Sales $8.054M Beat $7.875M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.24) by 12.5 percent. This is unchanged from the same period last year. The company
Benzinga Newsdesk
PRO
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.225M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.225 million estimate.
Benzinga Newsdesk
PRO
Rapid Micro Biosystems Q1 EPS $(0.31) Misses $(0.23) Estimate, Sales $8.002M Beat $7.600M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 19.23 percent decrease over losses of $(0.26) per
Benzinga Newsdesk
Earnings Scheduled For May 13, 2026
Benzinga Insights
Earnings Scheduled For March 12, 2026
Benzinga Insights
